“Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia”, Mediterr J Hematol Infect Dis, vol. 8, p. e2016016, Feb. 2016, doi: 10.4084/mjhid.2016.016.